Norges Bank’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.17M Buy
+142,100
New +$4.48M ﹤0.01% 1383
2026
Q1
Sell
-26,508
Closed -$992K 642
2025
Q4
$992K Buy
+26,508
New +$872K ﹤0.01% 1513
2025
Q3
Sell
-11,123
Closed -$351K 717
2025
Q2
$351K Sell
11,123
-42,927
-79% -$1.38M ﹤0.01% 1658
2025
Q1
$1.79M Sell
54,050
-414,360
-88% -$14.9M ﹤0.01% 1554
2024
Q4
$16.1M Buy
468,410
+64,791
+16% +$2.23M ﹤0.01% 1264
2024
Q3
$16.1M Buy
403,619
+275,631
+215% +$9.68M ﹤0.01% 1261
2024
Q2
$3.86M Sell
127,988
-37,767
-23% -$1.14M ﹤0.01% 1614
2024
Q1
$5.57M Sell
165,755
-11,803
-7% -$379K ﹤0.01% 1597
2023
Q4
$5.74M Sell
177,558
-12,770
-7% -$356K ﹤0.01% 1644
2023
Q3
$6.24M Hold
190,328
﹤0.01% 1630
2023
Q2
$6.7M Sell
190,328
-35,900
-16% -$1.24M ﹤0.01% 1647
2023
Q1
$7.39M Sell
226,228
-13,999
-6% -$638K ﹤0.01% 1666
2022
Q4
$13.2M Sell
240,227
-120,800
-33% -$6.64M ﹤0.01% 1460
2022
Q3
$16M Buy
+361,027
New +$17.6M ﹤0.01% 1324
2021
Q3
Sell
-72,800
Closed -$2.06M 2309
2021
Q2
$2.06M Buy
+72,800
New +$2.18M ﹤0.01% 2014

Other funds holding HRMY

Norges Bank's HRMY Position: Q2 2026 in Review

Norges Bank opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 142,100 shares worth $5.17M. The stake represents ﹤0.01% of the portfolio and ranks #1383 among its holdings. This is a return to the name: Norges Bank previously reported a position in HRMY as recently as Q4 2025.

Norges Bank first reported a position in HRMY in Q2 2021 and has held it in 15 quarters since. The position peaked at $16.1M in Q3 2024. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Norges Bank held 142,100 shares of Harmony Biosciences worth $5.17M as of Q2 2026.
  • Harmony Biosciences was a new Norges Bank position in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1383 holding.
  • Norges Bank first reported a position in Harmony Biosciences in Q2 2021 and has held it in 15 quarters since.
  • Norges Bank's Harmony Biosciences position peaked at $16.1M in Q3 2024.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.